by Redaktion LCGC | Jul 1, 2015
Evolutionary cancer modeling using growth kinetics of drug sensitive/resistant cells optimizes dosing strategies for EGFR-mutant NSCLC Chmielecki J, Foo J, Oxnard G, Hutchinson K, Ohashi K, Somwar R, Wang L, Amato KR, Arcila M, Sos ML, Socci ND, Viale A, de...